| India | Turchia | Austria | |
| Radioterapia per il cancro colorettale | da $3,200 | da $7,000 | da $12,000 |
| Chemioterapia per carcinoma mammario | da $3,500 | da $1,200 | da $15,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro del fegato stadio 2. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro del fegato stadio 2 e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro del fegato stadio 2.
La dottoressa è un'oncologa altamente qualificata specializzata nel trattamento di vari tipi di cancro, inclusi tumori solidi, tumori pediatrici e malignità ematologiche. È esperta in trattamenti sia conservativi che chirurgici, come la procedura di Whipple.<\/p>
Ha completato il suo MBBS al Lady Hardinge Medical College e il MD in medicina interna al Maulana Azad Medical College. Ha proseguito con il DM in Oncologia Medica al Tata Memorial Hospital, dove ha anche lavorato come consulente.<\/p>
È affiliata a società oncologiche internazionali e nazionali e ha esperienza in tumori polmonari, mammari, ginecologici e genitourinari, con un particolare interesse per l'immunoterapia e la terapia metronomica.<\/p>
Il dottore ha completato un MD in Medicina Interna presso il Shyam Shah Medical College e ha svolto una Residenza Senior nello stesso dipartimento. Successivamente, il dottore ha servito come Registrar in Oncologia Medica presso il Jawaharlal Nehru Cancer Hospital. Il dottore ha completato la formazione DNB in Oncologia Medica presso l'Indraprastha Apollo Hospital.<\/p>
Durante la Residenza Senior, il dottore ha tenuto lezioni alla Scuola Internazionale Invernale di Oncologia presso l'AIIMS e ha presentato ricerche sul Cancro allo Stomaco al Simposio sul Cancro Gastrointestinale della Società Americana di Oncologia Clinica. Il dottore è specializzato nella base molecolare del cancro e nelle terapie mirate.<\/p>
Il medico si è laureato in Medicina presso l'Università di Mysore nel 1996, seguito da un Dottorato in Medicina in radioterapia presso l'Università Hindu di Banaras nel 2002. Per migliorare ulteriormente la sua esperienza, il medico ha conseguito un Diploma del Consiglio Nazionale in radioterapia nel 2004.<\/p>
Il medico è membro di diverse organizzazioni prestigiose, tra cui l'Associazione di Oncologia Radioterapica dell'India, la Società di Neuro-Oncologia, il Gruppo di Oncologia di Bangalore e l'Associazione Indiana di Oncologia Ipertermica, riflettendo un forte impegno per l'avanzamento del campo dell'oncologia.<\/p>
Il medico è uno specialista esperto in medicina nucleare presso l'HCG Manavata Cancer Centre con 12 anni nel campo. Il medico si specializza in vari esami nucleari, esami PET-CT e servizi di cardiologia nucleare, dimostrando competenza nelle terapie con radioiodio e Lu-177 RN. Nel corso della sua carriera, il medico ha gestito oltre 30.000 esami PET e trattato oltre 1.000 pazienti con cancro alla tiroide. Inoltre, il medico ha contribuito al campo attraverso articoli pubblicati in varie riviste mediche.<\/p>
Stage 2 liver cancer is curable when the disease remains localized. Leading Indian centers achieve curative outcomes through surgical resection, liver transplantation, or thermal ablation. Success depends on liver function, tumor size, and the absence of vascular invasion or distant spread.
Bookimed Expert Insight: India has become a global leader in living donor liver transplants (LDLT). Global Hospital Chennai has performed over 1,000 successful transplants. While transplant is often the most definitive cure, our data shows that high-volume centers like HCG Manavata treat over 75,000 patients annually. This suggests that for many, sophisticated surgical resection or integrated oncological care is the more accessible curative path before considering a transplant.
Patient Consensus: Patients emphasize that a stage 2 diagnosis is only the starting point. Many note it is vital to confirm if a tumor is truly resectable by a hepatobiliary specialist before starting other therapies. They often recommend seeking a second opinion at a dedicated liver institute to ensure no time is lost on non-curative treatments.
India provides highly advanced minimally invasive alternatives for liver cancer patients unfit for major surgery. Leading centers utilize interventional radiology and robotic systems. These technologies allow for localized tumor destruction without large abdominal incisions. They significantly reduce physical trauma and recovery time.
Bookimed Expert Insight: Patient data shows Global Hospital Chennai is a standout for complex liver cases. It has performed over 1,000 successful liver transplants. This high volume often translates to expertise in non-surgical alternatives like robotic-assisted procedures. Choosing such a high-capacity center ensures access to the most precise linear accelerators available.
Patient Consensus: Patients note that being unfit for surgery does not mean options are exhausted. Many find relief through locoregional treatments like RFA which involve less pain and faster healing.
India features high-volume liver centers recognized by Newsweek and JCI for managing stage 2 hepatobiliary oncology. Leading hospitals include Global Hospital Chennai, which has performed over 1,000 liver transplants. Medanta and Apollo Delhi offer complex resections and advanced interventional radiology for vascular tumors.
Bookimed Expert Insight: Patients often focus on city location, but hospital volume is a more reliable quality indicator. For instance, Global Hospital Chennai and Apollo Hospital Delhi each serve over 1,000,000 patients annually. These high-volume centers typically maintain larger multidisciplinary tumor boards, which is essential when deciding between resection and transplant for stage 2 cases.
Patient Consensus: Patients emphasize the need for a dedicated hepatobiliary surgeon and a multidisciplinary tumor board rather than just a famous hospital name. Many recommend visiting tertiary centers like Tata Memorial for second opinions on surgical resectability before finalizing treatment.
Indian liver transplants primarily utilize living donors due to limited deceased donor availability. Healthy individuals between 18 and 55 with compatible blood types can donate a portion of their liver. Under the Transplantation of Human Organs Act, the liver naturally regenerates to full size within weeks.
Bookimed Expert Insight: India hosts massive transplant networks, with Apollo Hospital Indraprastha recognized as one of the largest centers in Asia. Global Hospital Chennai has successfully performed over 1,000 liver transplants. This high volume allows centers like Dr. Rela Institute to perform complex surgeries, including record-breaking pediatric cases, using advanced robotic systems.
Patient Consensus: Patients emphasize that being a willing donor is not enough. You must pass strict tests for fatty liver and blood compatibility before the legal committee even considers your case.
Stage 2 liver cancer patients in India can expect a 5-year survival rate between 35% and 37% on average. However, successful surgical outcomes significantly improve these odds. Liver transplant recipients often see 60% to 80% survival, while surgical resection outcomes typically range from 54% to 70%.
Bookimed Expert Insight: India excels in high-volume transplant surgery, which directly impacts long-term survival. Global Hospital Chennai has performed over 1,000 liver transplants. Dr. Mohamed Rela at Rela Institute holds a world record for pediatric transplant. Choosing such high-volume centers often ensures access to standardized post-surgical protocols that improve long-term outcomes.
Patient Consensus: Patients emphasize that success depends on truly curative surgery rather than temporary control. They note that survival feels more secure when underlying conditions like cirrhosis or hepatitis are managed alongside the cancer.
Indian health insurance covers liver cancer treatments like resection, ablation, TACE, and transplants. Standard indemnity plans and critical illness policies typically include these procedures. Approval depends on waiting periods, pre-existing condition clauses, and whether the hospital is JCI or NABH accredited.
Bookimed Expert Insight: High-volume centers like Global Hospital Chennai, which has performed over 1,000 liver transplants, often have specialized teams to handle insurance documentation. Selecting a facility with multiple accreditations like NABH and JCI can streamline the cashless approval process for complex Stage 2 oncology cases. This expertise reduces the likelihood of administrative claim denials for advanced procedures like TACE or ablation.
Patient Consensus: Patients note that while major surgeries are easier to claim, items like ICU consumables and imported drugs often require significant out-of-pocket payments. Pre-authorization is essential as cashless approval is never guaranteed, even in large hospital networks.
Minimizing liver cancer recurrence requires diligent medical surveillance and lifestyle management to protect liver health. Patients should prioritize regular imaging scans and alpha-fetoprotein blood tests. Managing underlying conditions like hepatitis or cirrhosis is vital. Maintaining a plant-forward diet and avoiding alcohol helps preserve liver function.
Bookimed Expert Insight: India’s leading oncology centers like HCG Manavata and Apollo Hospital Indraprastha emphasize a multi-disciplinary follow-up approach. While many focus on surgery, our data shows top specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries. This high volume highlights that long-term success depends on matching surgical skill with strict post-operative monitoring. Centers like Dr. Rela Institute use linear accelerators with 1 mm accuracy. Specialized technology helps target recurrences early when they are most treatable.
Patient Consensus: Patients emphasize that staying on top of scheduled imaging is the most important guard against silent recurrence. Many survivors note that managing diabetes and metabolic health was also a surprisingly critical factor in their recovery.